NCT06706362View on ClinicalTrials.gov

Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)

PHASE4RecruitingINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

April 15, 2027

Study Completion Date

October 15, 2027

Conditions

Stress Urinary Incontinence

Interventions

DRUG

Bactrim or Macrobid

Participants will be assigned to Bactrim or Macrobid depending on participants' allergies

DRUG

Placebo

Participants will be assigned to identical appearing placebo

Trial Locations (1)

43210

RECRUITING

The Ohio State University Wexner Medical Center OB/GYN Female Pelvic Medicine and Reconstructive Surgery, Columbus

All Listed Sponsors

lead

Ohio State University

OTHER

NCT06706362 - Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) | Biotech Hunter | Biotech Hunter